메뉴 건너뛰기




Volumn 12, Issue 12, 2010, Pages 1003-1012

RalBP1 is necessary for metastasis of human cancer cell lines

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EXOCYST; PHOSPHOLIPASE D1; RAL BINDING PROTEIN 1; RAL PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

EID: 78649852581     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.101080     Document Type: Article
Times cited : (53)

References (24)
  • 1
    • 38849147752 scopus 로고    scopus 로고
    • Ral GTPases and cancer: Linchpin support of the tumorigenic platform
    • Bodemann BO and White MA (2008). Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat Rev Cancer 8, 133-140.
    • (2008) Nat Rev Cancer , vol.8 , pp. 133-140
    • Bodemann, B.O.1    White, M.A.2
  • 2
    • 0029950722 scopus 로고    scopus 로고
    • A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation
    • White MA, Vale T, Camonis JH, Schaefer E, and Wigler MH (1996). A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J Biol Chem 271, 16439-16442.
    • (1996) J Biol Chem , vol.271 , pp. 16439-16442
    • White, M.A.1    Vale, T.2    Camonis, J.H.3    Schaefer, E.4    Wigler, M.H.5
  • 5
    • 35648970538 scopus 로고    scopus 로고
    • Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
    • Yin J, Pollock C, Tracy K, Chock M, Martin P, Oberst M, and Kelly K (2007). Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone. Mol Cell Biol 27, 7538-7550.
    • (2007) Mol Cell Biol , vol.27 , pp. 7538-7550
    • Yin, J.1    Pollock, C.2    Tracy, K.3    Chock, M.4    Martin, P.5    Oberst, M.6    Kelly, K.7
  • 8
    • 33644530955 scopus 로고    scopus 로고
    • Regression of melanoma in a murine model by RLIP76 depletion
    • Singhal SS, Awasthi YC, and Awasthi S (2006). Regression of melanoma in a murine model by RLIP76 depletion. Cancer Res 66, 2354-2360.
    • (2006) Cancer Res , vol.66 , pp. 2354-2360
    • Singhal, S.S.1    Awasthi, Y.C.2    Awasthi, S.3
  • 9
    • 34249322665 scopus 로고    scopus 로고
    • Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1)
    • Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, Awasthi YC, and Awasthi S (2007). Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res 67, 4382-4389.
    • (2007) Cancer Res , vol.67 , pp. 4382-4389
    • Singhal, S.S.1    Singhal, J.2    Yadav, S.3    Dwivedi, S.4    Boor, P.J.5    Awasthi, Y.C.6    Awasthi, S.7
  • 10
    • 0028921344 scopus 로고
    • Ras mediates the activation of phospholipase D by v-Src
    • Jiang H, Lu Z, Luo JQ, Wolfman A, and Foster DA (1995). Ras mediates the activation of phospholipase D by v-Src. J Biol Chem 270, 6006-6009.
    • (1995) J Biol Chem , vol.270 , pp. 6006-6009
    • Jiang, H.1    Lu, Z.2    Luo, J.Q.3    Wolfman, A.4    Foster, D.A.5
  • 11
    • 0034795116 scopus 로고    scopus 로고
    • Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts
    • Min DS, Kwon TK, Park WS, Chang JS, Park SK, Ahn BH, Ryoo ZY, Lee YH, Lee YS, Rhie DJ, et al. (2001). Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 22, 1641-1647.
    • (2001) Carcinogenesis , vol.22 , pp. 1641-1647
    • Min, D.S.1    Kwon, T.K.2    Park, W.S.3    Chang, J.S.4    Park, S.K.5    Ahn, B.H.6    Ryoo, Z.Y.7    Lee, Y.H.8    Lee, Y.S.9    Rhie, D.J.10
  • 14
    • 11144231663 scopus 로고    scopus 로고
    • Combination antiangiogenic and androgen deprivation therapy for prostate cancer: A promising therapeutic approach
    • Nicholson B, Gulding K, Conaway M, Wedge SR, and Theodorescu D (2004). Combination antiangiogenic and androgen deprivation therapy for prostate cancer: a promising therapeutic approach. Clin Cancer Res 10, 8728-8734.
    • (2004) Clin Cancer Res , vol.10 , pp. 8728-8734
    • Nicholson, B.1    Gulding, K.2    Conaway, M.3    Wedge, S.R.4    Theodorescu, D.5
  • 15
    • 33846846542 scopus 로고    scopus 로고
    • Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia
    • Wu Y, McRoberts K, Berr SS, Frierson HF Jr, Conaway M, and Theodorescu D (2007). Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Oncogene 26, 765-773.
    • (2007) Oncogene , vol.26 , pp. 765-773
    • Wu, Y.1    McRoberts, K.2    Berr, S.S.3    Frierson Jr., H.F.4    Conaway, M.5    Theodorescu, D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.